A Prospective Multicenter Study for Assessing MusiQoL Validity among Arabic-Speaking MS Patients Treated with Subcutaneous Interferon β-1a

Table 3

Overall and domain-specific SF-36 scores over time.

Variable	Initial visit (N =439)	6-month follow-up ()	12-month follow-up ()	value
SF-36 total score				0.215
General health				0.8186
Physical functioning				0.4063
Role limitations due to physical health				0.379
Role limitations due to emotional problems				0.4828
Energy/fatigue				0.3158
Emotional well-being				0.3539
Social functioning				0.038
Pain				0.2764

Values are ; values correspond to the change in overall and domain-specific MusiQoL scores across all 3 times points analysed using the nonparametric Friedman test.